Studies have shown that AP molecule downregulation can be overcome by exposure to IFNγ, such as that secreted by tumor-infiltrating immune cells, if the loss of AP component expression was not due to a genetic defect [65,70,73,75]. Here, DHCR7-DT is linked to neoplasm.